Abiopharma

🔍 Cotter Debra (Executive)

Company: WW INTERNATIONAL, INC. (WW)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 2,666 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-15 | Code: A | Expires: 2029-01-01 | equity_swap_involved: false | shares_owned_after: 2,666.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 1,200 shares of Performance Stock Unit (Derivative)
  Date: 2026-04-15 | Code: A | Expires: 2029-01-01 | equity_swap_involved: false | shares_owned_after: 1,200.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Each Restricted Stock Unit or Performance Stock Unit, as applicable, represents a contingent right to receive one share of Common Stock.
• F2: These awards granted on April 15, 2026 will vest one-third on each of January 1, 2027, January 1, 2028 and January 1, 2029.
• F3: Performance Stock Units ("PSUs") are subject to both service-based vesting conditions, requiring continued employment through January 1, 2029 (subject to limited customary exceptions), and a performance-based stock price vesting condition, with the number of PSUs that become eligible to vest determined based on (i) with respect to 50% of the PSUs, the volume weighted average closing price of the Common Stock of the Company, as measured over a period of 20 trading days ending on January 1, 2029, and (ii) with respect to 50% of the PSUs, the rolling 20-day volume weighted average closing price of the Common Stock of the Company, measured as of January 1, 2027 and each subsequent six month anniversary of January 1, 2027, through and including January 1, 2029.